DrCaleb DrCaleb:
This has been in the works for years. The problem is that in order to use an old drug for a new purpose, you have to do human trials first to study effects. But old drugs aren't patentable, and therefore drug companies won't make anything back in royalties. So, they don't want to fund the human trials.

I worked with Dr. Michelakis and that is essentially true. He would love to run extensive human trials, but they are very expensive to conduct (the $800k he raised initially was enough for 50 subjects) and pharma generally isn't interested in funding something they cannot patent.
However, this article calls it a cure for cancer, which is not - at least not yet. If you check on Youtube, there are a number of interviews with Dr. Michelakis (including one with Glenn Beck), and he is careful to note it is NOT a cure, but has potential for treating SOME forms of cancer.
Having said all of that, there are lots of researchers worldwide who are conducting their own studies on DCA, so this is hardly being ignored as this article claims.
http://www.clinicaltrials.gov/ct2/resul ... rch=Searchhttp://www.thedcasite.com/